SCHEMBL4657250

SCHEMBL4657250

COc1ccc(-c2ccc3c(c2)C(C)(C)[C@H]2COc4ccccc4[C@H]2N3OC)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 4/20 0.36
NPSR1 Q6W5P4 2/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BACE1 P56817 2/20 0.35
CYP19A1 P11511 1/20 0.34
ABCB1 P08183 2/20 0.34
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
POLB P06746 1/20 0.34
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HCRTR1 O43613 2/20 0.33
HCRTR2 O43614 2/20 0.33
BRD4 O60885 1/20 0.33
BRD2 P25440 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4564158 0.93 HTR2B (0.36) ALDH1A1GAAL3MBTL1BACE1HSP90AA1
SCHEMBL4564228 0.87 CACNA1B (0.35) DRD2DRD3HCRTR2BRD4BRD2
SCHEMBL4628825 0.86 RARB (0.39) HCRTR2BRD4BRD2BRD3
SCHEMBL4564105 0.85 PDE4A (0.37) HCRTR2BRD4BRD2BRD3PDK2
SCHEMBL4563452 0.85 PTGS2 (0.39) LMNAALDH1A1MAPTNPSR1GAA
SCHEMBL4564341 0.83 HSD11B1 (0.39) LMNAMAPTSMN1; SMN2DRD2DRD3
SCHEMBL4629499 0.83 HSP90AA1 (0.39) LMNAALDH1A1MAPTGAAL3MBTL1
SCHEMBL4564085 0.83 HSP90AA1 (0.39) ALDH1A1GAAL3MBTL1CYP19A1DRD2
SCHEMBL4658162 0.82 HCRTR2 (0.36) LMNAALDH1A1NPSR1GAAL3MBTL1
SCHEMBL4564518 0.82 LTB4R (0.38) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1907395-A1 ABCA1 ELEVATING COMPOUNDS CV THERAPEUTICS, INC. (US) 2008-04-09 EP disclosed
WO-2007002867-A1 ABCA1 ELEVATING COMPOUNDS CV THERAPEUTICS, INC. (US) 2007-01-04 WO disclosed